Drugs / Auto-hMSCs
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT01087996 | Mar 2010 → Apr 2011 | disease related to hematopoietic stem cell transplant | University of Miami | Completed | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Auto-hMSCs | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01087996 ↗ |
| Known as | Autologous human mesenchymal stem cells | “Biological: Autologous human mesenchymal stem cells (Auto-hMSCs)” NCT01087996 ↗ |
| Modality | Cell therapy | “Autologous human mesenchymal stem cells” NCT01087996 ↗ |
| Route | Other | “The injections will be administered transendocardially during cardiac catheterization” NCT01087996 ↗ |